Government allows Korean pharmaceutical companies to manufacture foreign new drugs and orphan drugs under contract

New drugs and orphan drugs whose technology transferred to a Korean manufacturer if sold in other countries will now be available to manufacturer under contract even in Korea.

As the Pharmaceutical Affairs Law is revised(24 October 2017) which extends the range of contract manufacturing businesses to register, the Ministry of Food and Drug Safety(MFDS) pre-announced on 31 January the ‘Partial ...